Photo by Shen Pan on Unsplash

Variational AI to participate in BIO Partnering @ JPM Week 2027

Each January, the J.P. Morgan Healthcare Conference turns San Francisco into the global epicenter of biotech, pharma, and healthcare investing. It is widely regarded as the industry’s largest and most influential healthcare investment symposium, bringing together global industry leaders, emerging biotech companies, and investors to set the tone for the year ahead.
Around the main conference, “JPM Week” has grown into a dense ecosystem of satellite meetings and curated partnering events, with more than 100 in-person and virtual gatherings listed in BIO’s JPM Events Guide

In 2027, Variational AI will be on the ground in San Francisco for the BIO Partnering @ JPM Week – January 11–14, 2027

Our delegation will include:

Handol Kim,
CEO

Pete Guzzo,
EVP & Head of Drug Discovery

Valentin Beuchillot,
Director, BD & Marketing

We’ll be meeting with biopharma and biotech partners to explore collaborations in AI-enabled small-molecule drug discovery, discuss pipeline and portfolio needs, and help teams accelerate hit finding and lead optimization. We look forward to connecting with you, building new partnerships, and kicking off 2027 on the right note.

If you’d like to schedule a meeting, please send us an email at bd@variational.ai or contact us directly through the BIO partnering platform.